K. Verma

Free Radicals as a Double-Edged Sword: The Cancer Preventive and Therapeutic Roles of Curcumin

S. Prasad, R. Lall, N. Gupta, 2020, Molecules.

Potent and Highly Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Act as Chemotherapeutic Potentiators in Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.

T. Penning, P. Trippier, T. Zang, 2019, Journal of medicinal chemistry.

Selective AKR1C3 Inhibitors Potentiate Chemotherapeutic Activity in Multiple Acute Myeloid Leukemia (AML) Cell Lines.

T. Penning, P. Trippier, T. Zang, 2016, ACS medicinal chemistry letters.

AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells

S. Srivastava, T. Penning, P. Trippier, 2018, Molecular Cancer Therapeutics.

Synthesis and Antineoplastic Evaluation of Mitochondrial Complex II (Succinate Dehydrogenase) Inhibitors Derived from Atpenin A5

P. Brookes, D. Pappas, Nihar Kinarivala, 2017, ChemMedChem.

Screening baccharin analogs as selective inhibitors against type 5 17β-hydroxysteroid dehydrogenase (AKR1C3).

T. Penning, P. Trippier, T. Zang, 2015, Chemico-biological interactions.

Primary Amine Tethered Small Molecules Promote the Degradation of X-Linked Inhibitor of Apoptosis Protein.

Melinda M. Mulvihill, I. Wertz, W. Fairbrother, 2021, Journal of the American Chemical Society.